Correspondence 0001387131-23-009026 from Adamis Pharmaceuticals Corp (DMKPQ) (CIK 0000887247)
Adamis Pharmaceuticals Corp (DMKPQ) (CIK 0000887247)
Date: July 28, 2023 · CIK: 0000887247 · Accession: 0001387131-23-009026
AI Filing Summary & Sentiment
File numbers found in text: 333-273233
Show Raw Text
CORRESP
1
filename1.htm
July 28, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Adamis Pharmaceuticals Corporation
Registration Statement on Form S-1
File No. 333-273233
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence
via EDGAR on July 26, 2023, in which we, as placement agent for the above-referenced offering, joined in the request of Adamis Pharmaceuticals
Corporation (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement for
July 28, 2023, at 9:00 a.m. Eastern Time. The Company is no longer requesting that such Registration Statement be declared effective at
this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
MAXIM GROUP LLC
By:
/s/ Clifford A. Teller
Name:
Clifford A. Teller
Title:
Co-President